METHODS OF TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240230644A1
SERIAL NO

18382562

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are methods for reducing or arresting an increase in a Neuropathy Impairment Score (NIS) or a modified NIS (mNIS+7) in a human subject by administering an effective amount of a transthyretin (TTR)-inhibiting composition.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALNYLAM PHARMACEUTICALS INC300 THIRD STREET CAMBRIDGE MA 02142-1110

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bettencourt, Brian Groton, US 134 658

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation